Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (9006)
All Articles published online
|
Publishing Process of This Article
|
Mar 21, 2015 (publication date) through Apr 23, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Sanal MG. Biomarkers in nonalcoholic fatty liver disease-the emperor has no clothes? World J Gastroenterol 2015; 21(11): 3223-3231 [PMID: 25805928 DOI: 10.3748/wjg.v21.i11.3223] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v21/i11/3223.htm |
| Number | Citing Articles |
| 1 |
Moein Askarpour, Kurosh Djafarian, Ehsan Ghaedi, Omid Sadeghi, Ali Sheikhi, Sakineh Shab-Bidar. Effect of L-Carnitine Supplementation on Liver Enzymes: A Systematic Review and Meta-analysis of Randomized Controlled Trials. Archives of Medical Research 2020; 51(1): 82 doi: 10.1016/j.arcmed.2019.12.005
|
| 2 |
Irene Cantero, Itziar Abete, Josep Maria del Bas, Antoni Caimari, Lluís Arola, M. Angeles Zulet, J. Alfredo Martinez. Changes in lysophospholipids and liver status after weight loss: the RESMENA study. Nutrition & Metabolism 2018; 15(1) doi: 10.1186/s12986-018-0288-5
|
| 3 |
Madhusudana Girija Sanal. Is the change from NAFLD to MASLD driven by political correctness?. Journal of Hepatology 2024; 80(2): e74 doi: 10.1016/j.jhep.2023.08.027
|
| 4 |
Pedro Paulo Caravatto, Ricardo Cohen. The Role of Metabolic Surgery in Non-alcoholic Steatohepatitis Improvement. Current Atherosclerosis Reports 2017; 19(11) doi: 10.1007/s11883-017-0681-y
|
| 5 |
Mabel Graffigna, Natalia Catoira, Jimena Soutelo, Andreína Azpelicueta, Gabriela Berg, Cecilia Perel, Marta Elena Migliano, Marcela Aranguren, Carla Musso, Javier Farias. Diagnóstico de esteatosis hepática por métodos clínicos, bioquímicos y por imágenes. Revista Argentina de Endocrinología y Metabolismo 2017; 54(1): 37 doi: 10.1016/j.raem.2016.12.001
|
| 6 |
Brandon J Perumpail, Muhammad Ali Khan, Eric R Yoo, George Cholankeril, Donghee Kim, Aijaz Ahmed. Clinical epidemiology and disease burden of nonalcoholic fatty liver disease. World Journal of Gastroenterology 2017; 23(47): 8263-8276 doi: 10.3748/wjg.v23.i47.8263
|
| 7 |
E.P.S. Conceição, E.G. Moura, P.N. Soares, X.X. Ai, M.S. Figueiredo, E. Oliveira, P.C. Lisboa. High calcium diet improves the liver oxidative stress and microsteatosis in adult obese rats that were overfed during lactation. Food and Chemical Toxicology 2016; 92: 245 doi: 10.1016/j.fct.2016.04.015
|
| 8 |
Long Wang, Jinghui Guo, Jianping Lu. Risk factor compositions of nonalcoholic fatty liver disease change with body mass index in males and females. Oncotarget 2016; 7(24): 35632 doi: 10.18632/oncotarget.9691
|
| 9 |
E. P. S. Conceição, E. G. Moura, J. C. Carvalho, E. Oliveira, P. C. Lisboa. Early redox imbalance is associated with liver dysfunction at weaning in overfed rats. The Journal of Physiology 2015; 593(21): 4799 doi: 10.1113/JP271189
|
| 10 |
Elena V. Vinnitskaya, Yuliay G. Sandler, Kirill G. Saliev, Anton N. Ivanov, Evgenia S. Sbikina, Tatyana Yu. Khaymenova, Dmitry S. Bordin. Efficacy of human placenta hydrolyzate in the treatment of patients with metabolic associated fatty liver disease at the stage of fibrosis (pilot study). Terapevticheskii arkhiv 2024; 96(2): 107 doi: 10.26442/00403660.2024.02.202582
|
| 11 |
Irene Cantero, Itziar Abete, Nancy Babio, Fernando Arós, Dolores Corella, Ramón Estruch, Montse Fitó, James R. Hebert, M. Ángel Martínez-González, Xavier Pintó, M. Puy Portillo, Miguel Ruiz-Canela, Nitin Shivappa, Julia Wärnberg, Enrique Gómez-Gracia, J. Antoni Tur, Jordi Salas-Salvadó, M. Angeles Zulet, J. Alfredo Martínez. Dietary Inflammatory Index and liver status in subjects with different adiposity levels within the PREDIMED trial. Clinical Nutrition 2018; 37(5): 1736 doi: 10.1016/j.clnu.2017.06.027
|
| 12 |
Chieh-Chen Wu, Wen-Chun Yeh, Wen-Ding Hsu, Md. Mohaimenul Islam, Phung Anh (Alex) Nguyen, Tahmina Nasrin Poly, Yao-Chin Wang, Hsuan-Chia Yang, Yu-Chuan (Jack) Li. Prediction of fatty liver disease using machine learning algorithms. Computer Methods and Programs in Biomedicine 2019; 170: 23 doi: 10.1016/j.cmpb.2018.12.032
|
| 13 |
Aijaz Ahmed, Robert J. Wong, Stephen A. Harrison. Nonalcoholic Fatty Liver Disease Review: Diagnosis, Treatment, and Outcomes. Clinical Gastroenterology and Hepatology 2015; 13(12): 2062 doi: 10.1016/j.cgh.2015.07.029
|
| 14 |
Nancy de los Ángeles Segura-Azuara, Carlos Daniel Varela-Chinchilla, Plinio A. Trinidad-Calderón. MAFLD/NAFLD Biopsy-Free Scoring Systems for Hepatic Steatosis, NASH, and Fibrosis Diagnosis. Frontiers in Medicine 2022; 8 doi: 10.3389/fmed.2021.774079
|
| 15 |
Nikhil S. Bhandarkar, Lindsay Brown, Sunil K. Panchal. Chlorogenic acid attenuates high-carbohydrate, high-fat diet–induced cardiovascular, liver, and metabolic changes in rats. Nutrition Research 2019; 62: 78 doi: 10.1016/j.nutres.2018.11.002
|
| 16 |
Ming-Ling Chang, Jing-Hong Hu, Ching-Hao Yen, Kuan-Hsing Chen, Chia-Jung Kuo, Ming-Shyan Lin, Cheng-Han Lee, Shiang-Chi Chen, Rong-Nan Chien. Evolution of ferritin levels in hepatitis C patients treated with antivirals. Scientific Reports 2020; 10(1) doi: 10.1038/s41598-020-76871-z
|
| 17 |
Eugenia Tsai, Tai-Ping Lee. Diagnosis and Evaluation of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis, Including Noninvasive Biomarkers and Transient Elastography. Clinics in Liver Disease 2018; 22(1): 73 doi: 10.1016/j.cld.2017.08.004
|
| 18 |
Riki Toita, Jeong-Hun Kang. Long-term profile of serological biomarkers, hepatic inflammation, and fibrosis in a mouse model of non-alcoholic fatty liver disease. Toxicology Letters 2020; 332: 1 doi: 10.1016/j.toxlet.2020.06.020
|
| 19 |
Chutima Leelalertlauw, Manassawee Korwutthikulrangsri, Pat Mahachoklertwattana, Suwannee Chanprasertyothin, Patcharin Khlairit, Sarunyu Pongratanakul, Preamrudee Poomthavorn. Serum glypican 4 level in obese children and its relation to degree of obesity. Clinical Endocrinology 2017; 87(6): 689 doi: 10.1111/cen.13435
|
| 20 |
Mahdi Barazesh, Sajad Jalili, Morteza Akhzari, Fouzieyeh Faraji, Ebrahim Khorramdin. Recent Progresses on Pathophysiology, Diagnosis, Therapeutic Modalities,
and Management of Non-alcoholic Fatty Liver Disorder. Current Drug Therapy 2024; 19(1): 20 doi: 10.2174/1574885518666230417111247
|
| 21 |
Laura Marino, François R Jornayvaz. Endocrine causes of nonalcoholic fatty liver disease. World Journal of Gastroenterology 2015; 21(39): 11053-11076 doi: 10.3748/wjg.v21.i39.11053
|
| 22 |
Somaya Albhaisi, Arun J. Sanyal. Applying Non-Invasive Fibrosis Measurements in NAFLD/NASH: Progress to Date. Pharmaceutical Medicine 2019; 33(6): 451 doi: 10.1007/s40290-019-00305-z
|
| 23 |
Mitsutaka Kohno, Hideo Sugano, Yuhko Shigihara, Yoshiaki Shiraishi, Takayasu Motoyama. Improvement of glucose and lipid metabolism via mung bean protein consumption: clinical trials of GLUCODIA™ isolated mung bean protein in the USA and Canada. Journal of Nutritional Science 2018; 7 doi: 10.1017/jns.2017.68
|
| 24 |
Mah I Kan Changez, Maryam Mubeen, Monezahe Zehra, Inara Samnani, Aniqa Abdul Rasool, Anmol Mohan, Um Ul Wara, Usha Tejwaney, Vikash Kumar. Role of microRNA in non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH): a comprehensive review. Journal of International Medical Research 2023; 51(9) doi: 10.1177/03000605231197058
|
| 25 |
D A Zhaldak, O K Melekhovets, V F Orlovskyi. CYP7A1 gene polymorphism and the characteristics of dyslipidemias in patients with nonalcoholic fatty liver disease concurrent with hypothyroidism. Terapevticheskii arkhiv 2017; 89(10): 62 doi: 10.17116/terarkh2017891062-65
|
| 26 |
Filiz Fusun Bolukbas, Seyda İgnak, Ozlem Unay Demirel, Yavuz Furuncuoglu, Ferhan Mantar, Sercen Cansu Sertel, Filiz Yarimcan Saglam, Cengiz Bolukbas. Alkole bağlı olmayan karaciğer yağlanmasında transient elastografi (Fibroscan) tekniği ile tespit edilen fibrozis skoru ile serum Vitamin B12 arasındaki ilişkinin araştırılması. Anadolu Kliniği Tıp Bilimleri Dergisi 2017; doi: 10.21673/anadoluklin.297152
|
| 27 |
Stephen A. Harrison, Salvatore Calanna, Kenneth Cusi, Martin Linder, Takeshi Okanoue, Vlad Ratziu, Arun Sanyal, Anne-Sophie Sejling, Philip N. Newsome. Semaglutide for the treatment of non-alcoholic steatohepatitis: Trial design and comparison of non-invasive biomarkers. Contemporary Clinical Trials 2020; 97: 106174 doi: 10.1016/j.cct.2020.106174
|
| 28 |
Joost Boeckmans, Alessandra Natale, Karolien Buyl, Vera Rogiers, Joery De Kock, Tamara Vanhaecke, Robim M. Rodrigues. Human-based systems: Mechanistic NASH modelling just around the corner?. Pharmacological Research 2018; 134: 257 doi: 10.1016/j.phrs.2018.06.029
|
| 29 |
Victoria Higgins, Arghavan Omidi, Houman Tahmasebi, Shervin Asgari, Kian Gordanifar, Michelle Nieuwesteeg, Khosrow Adeli. Marked Influence of Adiposity on Laboratory Biomarkers in a Healthy Cohort of Children and Adolescents. The Journal of Clinical Endocrinology & Metabolism 2020; 105(4): e1781 doi: 10.1210/clinem/dgz161
|
| 30 |
Dachuan Jin, Zhongfeng Cui, Shunqin Jin, Tao Zhou, Baoqiang Guo, Peng Gao, Guangming Li. Comparison of efficacy of anti-diabetics on non-diabetic NAFLD: A network meta-analysis. Frontiers in Pharmacology 2023; 13 doi: 10.3389/fphar.2022.1096064
|
| 31 |
Viera Kupčová, Michaela Fedelešová, Jozef Bulas, Petra Kozmonová, Ladislav Turecký. Overview of the Pathogenesis, Genetic, and Non-Invasive Clinical, Biochemical, and Scoring Methods in the Assessment of NAFLD. International Journal of Environmental Research and Public Health 2019; 16(19): 3570 doi: 10.3390/ijerph16193570
|